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Objective
Genomic analysis technologies are enabling an unprece-
dented characterization of human molecular variability.
This high analytical power will be essential to meet the
challenge of personalized medicine. More than ever, the
quality of the biological samples will be essential to
make the most of these new technologies. In order to
obtain a large collection of samples from patients with
Immune Mediated Inflammatory Diseases (IMIDs), the
IMID-Biobank was created in 2008.
Methods
The IMID-Biobank is located in the Scientific Park of
Barcelona. In collaboration with the Spanish National
DNA Bank (www.bancoadn.org) different working proto-
cols were implemented, regarding the collection, proces-
sing and storage of the IMID samples. The IMID-Biobank
is itself an operating infrastructure that consists of a steer-
ing unit, a technical coordinator, a team of laboratory
technicians and quality control unit. The purpose of
the biobank, to provide samples of high quality, depends
on the proper coordination of each of these elements. For
this purpose, the IMID-Biobank has implemented a qual-
ity management system that allows continuous evaluation
of all processes and procedures that take place in the
biobank.
Results
The IMID-Biobank has collected, processed and stored
samples from more than 8,000 patients with IMID dis-
eases. Taking into account that from blood samples differ-
ent products like genomic DNA, RNA, plasma or
immortalized cell lines can be obtained, the IMID-Biobank
is actually storing more than 50,000 products derived from
IMID patients. The IMID-Biobank is the first Spanish bio-
bank associated with a hospital that obtains the ISO
9001:2000 quality certificate.
Conclusions
The existence of biobanks like IMID-Biobank will be
essential to make the most of genomic technologies and
finally meet the challenge of personalized medicine.
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